May 01, 2019 / 08:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Vanda Pharmaceuticals First Quarter 2019 Earnings Conference Call. (Operator Instructions) As a reminder, today's conference is being recorded.
I'd now like to introduce your host for today's conference, Mr. Jim Kelly, Executive Vice President and Chief Financial Officer. Sir, please go ahead.
James Patrick Kelly - Vanda Pharmaceuticals Inc. - Executive VP, CFO & Treasurer
All right. Thank you, Liz. Good afternoon and thank you for joining us to discuss Vanda Pharmaceuticals' first quarter 2019 performance. Our first quarter 2019 results were released this afternoon and are available on the SEC EDGAR System and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website.
Joining me on today's call is Dr. Mihales Polymeropoulos, our President and CEO. Following my introductory remarks, Mihales will update you on our ongoing activities, I will then
Q1 2019 Vanda Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot